What is the RADX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Radiopharm Theranostics Limited (RADX) price will be around $2.54 in the next 2 weeks. This means it will decrease by -20.625000000000004 from the last closing price. This prediction may vary from other time period filters for RADX stock.

What can be the highest Possible price of RADX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, RADX can achieve the highest price of $2.73 which is -14.551047731817244 lower than last closing price. This prediction may vary from other time period filters for RADX stock.

What can be the lowest Possible price of RADX stock in next 2 weeks?

As per the forecast and algorithmic analysis, RADX stock price can be as low as $2.35 which is -26.533208682262593 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for RADX stock.

Will RADX stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that RADX stock will lose-20.625000000000004 in the next 2 weeks. This prediction may vary from other time period filters for RADX stock.

What is RADX stock last closing price?

Last closing price of RADX stock was $3.15.

What is RADX stock price prediction?

RADX stock price prediction means predicting the future closing prices of RADX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of RADX stock in a certain time period.

How we predict RADX stock future prices?

If you are searching for RADX stock forecast, analysis or price prediction, then you might be wondering what Radiopharm Theranostics Limited (RADX) will do in the future. Our RADX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This RADX price prediction will likely answer most of your questions.

How frequent we update RADX stock predictions?

We are updating the forecasts for the RADX stock on daily basis.

Is using ML forecasting for RADX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for RADX stock same for all the time periods?

No, the prediction for RADX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Radiopharm Theranostics Limited Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$3.15-28.89%Since 2 Weeks

Predicted Price$2.54-20.63%For 2 Weeks

Upper Predicted Price$2.73-14.55%For 2 Weeks

Lower Predicted Price$2.35-26.53%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of RADX will decline by -20.63% over the next 2 Weeks and hit $2.54 by Thursday, August 13, 2026. In that time frame, RADX's share price is expected to range between $2.35 and $2.73.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 13, 2026	2.35	2.54	2.73
Aug 12, 2026	2.33	2.52	2.70
Aug 11, 2026	2.38	2.55	2.73
Aug 10, 2026	2.46	2.63	2.82
Aug 7, 2026	2.52	2.69	2.87
Aug 6, 2026	2.69	2.86	3.04
Aug 5, 2026	2.67	2.84	3.02
Aug 4, 2026	2.70	2.88	3.04
Aug 3, 2026	2.78	2.96	3.13
Jul 31, 2026	2.83	3.01	3.19

RADX shares fell -1.56% in Friday, July 31, 2026's trading session, dropping from a previous close of $3.20 to move at $3.15. The stock demonstrated notable intraday movement (see RADX's key stats for a full breakdown), fluctuating between $2.95 and $3.24, a +9.83% trading range. While recent weeks have seen some volatility, RADX has managed to secure a -26.57% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 93.67K shares changing hands, 26.74K more than the previous session. This amounted to $295.07K in total market activity.

Will RADX Continue Its Downward Trend?

According to analyst ratings and projections for RADX, Radiopharm Theranostics Limited shares are anticipated to decrease by -15.20%, potentially reaching $2.73 per share by August 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for RADX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the RADX stock forecast, now is not the best time to buy RADX stock because its current trading price is +24.02% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RADX covering social and institutional perspectives.

RADX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into RADX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 20.27% to 29.89%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 39.95%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 43.62%, maintains a neutral outlook for the long term. Insights into RADX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Radiopharm Theranostics Short-Term Forecasts

RADX Forecast For Next 5 Days

Our algorithm anticipates Radiopharm Theranostics (RADX) stock could hit $3.16 by Aug 07, 2026. This represents a +0.31% fall from today's price, following a -2.72% change over the past five days.

RADX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Radiopharm Theranostics Limited (RADX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.07, which would mean a -2.54% decrease from the current price of $3.15. Projections for this period range from a high of $3.54 to a low of $2.37.

RADX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Radiopharm Theranostics's price over the next three months point to a rise. RADX stock is expected to peak at $18.03 on Oct 12, 2026 after potentially dipping to $8.64 on Aug 14, 2026. On average, RADX is likely to trade around $13.11 in the coming 90 days.

Radiopharm Theranostics Stock Forecast 2025

Based on our predictive models, Radiopharm Theranostics (RADX) is expected to trade between $8.64 and $18.03 throughout 2026. This would result in an average price of $11.99, potentially offering investors a +280.63% return from current levels.

Radiopharm Theranostics Limited Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Radiopharm Theranostics Limited (RADX) is positioned to show a strong performance in July 2026. The price is predicted to move between $9.08 and $9.36, settling at an average of $9.21. This could translate to a +192.38% gain.

August 2026

Based on current market signals, Radiopharm Theranostics Limited is projected to trend august 2026. We forecast a trading range from $8.64 to $12.85, with a likely average price of $9.80. Investors could expect a potential return of +211.11%.

September 2026

Our predictive algorithms indicate Radiopharm Theranostics Limited stock may see a shift in September 2026. The expected range spans $12.59–$16.03, with an average target of $14.96. This represents a positive outlook and a possible gain of +374.92%.

October 2026

Analyzing established trends, Radiopharm Theranostics Limited looks set to move in October 2026. Projections place the stock between $11.05 and $18.03, averaging around $14.58. This suggests a +362.86% gain from current levels.

November 2026

Market indicators suggest Radiopharm Theranostics Limited could experience notable changes during November 2026. Prices could fluctuate within $8.73 to $10.58, with a midpoint forecast of $9.34. The stock might deliver a +196.51% gain.

December 2026

Forecasting for December 2026, models estimate that Radiopharm Theranostics Limited may undergo key fluctuations. If trends hold, the stock might trade between $9.89 and $12.72, averaging $11.19. This signals a positive trajectory with potential returns around +255.24%.

January 2027

According to our latest forecast models, Radiopharm Theranostics Limited (RADX) is positioned to show a strong performance in January 2027. The price is predicted to move between $7.55 and $10.52, settling at an average of $8.81. This could translate to a +179.68% gain.

February 2027

Based on current market signals, Radiopharm Theranostics Limited is projected to trend february 2027. We forecast a trading range from $10.97 to $12.43, with a likely average price of $11.79. Investors could expect a potential return of +274.29%.

March 2027

Our predictive algorithms indicate Radiopharm Theranostics Limited stock may see a shift in March 2027. The expected range spans $8.27–$12.66, with an average target of $10.74. This represents a positive outlook and a possible gain of +240.95%.

April 2027

Analyzing established trends, Radiopharm Theranostics Limited looks set to move in April 2027. Projections place the stock between $7.84 and $9.97, averaging around $9.15. This suggests a +190.48% gain from current levels.

May 2027

Market indicators suggest Radiopharm Theranostics Limited could experience notable changes during May 2027. Prices could fluctuate within $7.94 to $10.89, with a midpoint forecast of $9.25. The stock might deliver a +193.65% gain.

June 2027

Forecasting for June 2027, models estimate that Radiopharm Theranostics Limited may undergo key fluctuations. If trends hold, the stock might trade between $6.30 and $9.20, averaging $7.43. This signals a positive trajectory with potential returns around +135.87%.

July 2027

According to our latest forecast models, Radiopharm Theranostics Limited (RADX) is positioned to show a strong performance in July 2027. The price is predicted to move between $7.63 and $10.43, settling at an average of $9.46. This could translate to a +200.32% gain.

RADX's history of dividends and stock splits also plays a role in long-term investor confidence.